BioSpace News Archive

Thermo Fisher Scientific Inc., the world leader in serving science, announced it will build a state-of-the-art manufacturing facility in Mebane, N.C.

Today, the U.S. Food and Drug Administration approved Besremi (ropeginterferon alfa-2b-njft) injection to treat adults with polycythemia vera, a blood disease that causes the overproduction of red blood cells.

Aimmune Therapeutics, Inc., today presented results from longitudinal analyses evaluating immunological outcomes of long-term daily oral immunotherapy (OIT) with PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp].

HydroCision Inc., a medical device company that pioneered high velocity, heat-free, FluidJet™ technology for surgical resection, congratulates PROCEPT BioRobotics on the recent closing of its upsized initial public offering.

Today, the U.S. Food and Drug Administration is providing an update related to the June 14, 2021, recall of certain Philips Respironics ventilators, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) machines.

Rockwell Medical, Inc., a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, announced that a majority of the independent directors serving on the Company’s Board of Directors approved option grants to two new employees to purchase an aggregate of 75,000 shares of the Company’s common stock.

Rezolute, Inc., a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, announced its financial results for the first quarter of fiscal 2022 ended September 30, 2021.

Jasper Therapeutics, Inc. (Nasdaq: JSPR), a biotechnology company focused on hematopoietic cell transplant therapies, today announced results for the quarter ended September 30, 2021, and provided a business update.

Rani Therapeutics Holdings, Inc., a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics, announced the appointment of Lyn Baranowski to its Board of Directors.

ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer and Ori Gon, Chief Financial Officer will present at H.C.WAINWRIGHT 7th annual Israel virtual conference held on November 15, 2021, the event is virtual and includes company presentation and 1-on-1 meetings.